UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.12B |
| 2 |
Apple
AAPL
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
Nike
NKE
|
+$1.03B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$821M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$389M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$383M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$348M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$263M |
| 5 |
NRG Energy
NRG
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.8% |
| 2 | Financials | 8.25% |
| 3 | Healthcare | 6.4% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Communication Services | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
First Solar
FSLR
$25B
| $134M | 0.03% |
595,271
+141,532
| +31% | +$30.9M |
|
502
Vanguard Intermediate-Term Bond ETF
BIV
$28.8B
| $134M | 0.03% |
1,789,786
-38,607
| -2% | -$2.87M |
|
503
First Trust Capital Strength ETF
FTCS
$7.86B
| $134M | 0.03% |
1,591,823
-52,339
| -3% | -$4.37M |
|
504
Equinix
EQIX
$102B
| $134M | 0.03% |
176,523
-28,807
| -14% | -$21.9M |
|
505
Dimensional Emerging Core Equity Market ETF
DFAE
$9.38B
| $133M | 0.03% |
5,159,949
+43,711
| +0.9% | +$1.11M |
|
|
XYZ
506
Block Inc
XYZ
$48.9B
| $133M | 0.03% |
2,065,256
+183,424
| +10% | +$12.8M |
|
507
Alerian MLP ETF
AMLP
$13B
| $133M | 0.03% |
2,772,264
+61,423
| +2% | +$2.87M |
|
508
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.6B
| $133M | 0.03% |
2,238,981
+3,618
| +0.2% | +$208K |
|
509
Rio Tinto
RIO
$156B
| $132M | 0.03% |
2,006,942
+1,125,998
| +128% | +$76.6M |
|
510
Super Micro Computer
SMCI
$18.5B
| $132M | 0.03% |
1,612,260
+61,300
| +4% | +$5.24M |
|
511
Ulta Beauty
ULTA
$23B
| $132M | 0.03% |
340,992
+110,347
| +48% | +$44.9M |
|
512
Ford
F
$57.5B
| $131M | 0.03% |
10,483,488
+1,073,763
| +11% | +$13.3M |
|
513
CALL
VanEck Gold Miners ETF
GDX
$23.2B
| $131M | 0.03% |
3,867,672
-3,359,648
| -46% | -$115M |
|
514
American Water Works
AWK
$26.1B
| $131M | 0.03% |
1,013,530
-11,437
| -1% | -$1.45M |
|
|
NVO
515
Novo Nordisk
NVO
$208B
| $130M | 0.03% |
914,199
+148,546
| +19% | +$19.7M |
|
516
HCA Healthcare
HCA
$88B
| $130M | 0.03% |
406,125
-156
| -0% | -$50.7K |
|
517
CALL
UnitedHealth
UNH
$377B
| $130M | 0.03% |
254,700
-34,800
| -12% | -$17.1M |
|
518
PUT
VanEck Semiconductor ETF
SMH
$68.5B
| $129M | 0.03% |
495,900
+148,600
| +43% | +$34.8M |
|
519
CALL
Eli Lilly
LLY
$1,000B
| $129M | 0.03% |
142,554
-24,346
| -15% | -$19.5M |
|
520
Arthur J. Gallagher & Co
AJG
$63.7B
| $129M | 0.03% |
496,541
+26,320
| +6% | +$6.53M |
|
521
Monster Beverage
MNST
$91.5B
| $129M | 0.03% |
2,574,640
+159,517
| +7% | +$8.45M |
|
522
Moderna
MRNA
$21.9B
| $128M | 0.03% |
1,081,761
+64,573
| +6% | +$8.17M |
|
523
Realty Income
O
$59.2B
| $128M | 0.03% |
2,417,588
-1,112,888
| -32% | -$59.4M |
|
524
PPG Industries
PPG
$25.3B
| $128M | 0.03% |
1,014,098
+52,255
| +5% | +$6.92M |
|
525
CALL
Chevron
CVX
$385B
| $128M | 0.03% |
815,522
-349,790
| -30% | -$55.8M |
|
Similar funds
UBS Group's Q2 2024 Portfolio in Review
As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
- UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
- UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
- UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
- UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
- UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
- UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.
Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.